Skip to main content

Advertisement

Log in

Neuropeptide α-MSH exerts pro-inflammatory effects on Neisseria meningitidis infection in vitro

  • Original Research Paper
  • Published:
Inflammation Research Aims and scope Submit manuscript

Abstract

Objective and design

α-Melanoycte stimulating hormone (α-MSH), a neuropeptide hormone with reported anti-microbial and immuno-modulatory properties in vitro, has previously been detected in the cerebrospinal fluid of children with bacterial meningitis. We investigated the therapeutic effects of α-MSH administration on Neisseria meningitidis infection of human meningeal cell cultures in vitro.

Materials and methods

Meningeal cell lines (n = 2) were infected with meningococci (102–108 cfu/monolayer), isolated bacterial outer membranes (OM; 1 μg/ml) or lipo-oligosaccharide (LOS; 1 μg/ml) with and without α-MSH (10−5–10 μM). Bacterial adherence was quantified at 6 h, and cytokine production and microbicidal activity of α-MSH for meningococci were assessed at 24 h.

Results

Compared with infection by meningococci alone, α-MSH (10 μM) up-regulated secretion of IL-6 and IL-8 (mean values increased from ~33 to 60 ng/ml), RANTES (mean values increased from ~26 to 105 ng/ml) and GM-CSF (mean values increased from ~0.3 to 1 ng/ml; P < 0.05). Upregulated secretion correlated with a neuropeptide-mediated rapid and >5-fold increase (P < 0.05) in bacterial adherence to cells and was dependent on OM components including LOS acting synergistically with α-MSH. Meningococci were resistant to the anti-microbial activity of α-MSH at all concentrations tested.

Conclusions

Our study demonstrates that a potentially therapeutic neuropeptide exerts pro-inflammatory effects during meningococcal infection in vitro and its use in the treatment of meningitis is contra-indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. van Deuren M, Brandtzaeg P, van der Meer J. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev. 2000;13:144–66.

    Article  PubMed  Google Scholar 

  2. Weller RO. Nervous system. In: Berry MM, Standring SM, Bannister LH, editors. Grays anatomy. London: Churchill Livingstone; 1995. p. 901–1398.

    Google Scholar 

  3. Brandtzaeg P. Pathogenesis of meningococcal infections. In: Cartwright KAV, editor. Meningococcal disease. UK: Wiley; 1995. p. 71–114.

    Google Scholar 

  4. Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am. 1999;13:527–48.

    Article  CAS  PubMed  Google Scholar 

  5. Weber JR, Tuomanen E. Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol. 2007;184:45–52.

    Article  CAS  PubMed  Google Scholar 

  6. Christodoulides M, Heckels JE, Weller RO. The role of the leptomeninges in meningococcal meningitis. In: Ferreiros C, Criado MT, Vazquez J, editors. Emerging strategies in the fight against meningitis. UK: Horizon Press; 2002. p. 1–37.

    Google Scholar 

  7. Stolzenberg ED, Anderson GM, Ackermann MR, Whitlock RH, Zasloff M. Epithelial antibiotic induced in states of disease. Proc Natl Acad Sci USA. 1997;94:8686–90.

    Article  CAS  PubMed  Google Scholar 

  8. Bergman P, Johansson L, Wan H, Jones A, Gallo RL, Gudmundsson GH, et al. Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection. Infect Immun. 2006;74:6982–91.

    Article  CAS  PubMed  Google Scholar 

  9. Ichiyama T, Nishikawa M, Hayashi T, Hayashi S, Ryozawa M, Furukawa S. Cerebrospinal fluid concentrations of alpha-melanocyte-stimulating hormone in bacterial and aseptic meningitis. Acta Paediatr. 2000;89:803–5.

    Article  CAS  PubMed  Google Scholar 

  10. Hadley ME, Haskell-Luevano C. The proopiomelanocortin system. Ann NY Acad Sci. 1999;885:1–21.

    Article  CAS  PubMed  Google Scholar 

  11. Catania A, Colombo G, Rossi C, Carlin A, Sordi A, Lonati C, et al. Antimicrobial properties of alpha-MSH and related synthetic melanocortins. ScientificWorldJournal. 2006;6:1241–6.

    Article  CAS  PubMed  Google Scholar 

  12. Donnarumma G, Paoletti I, Buommino E, Tufano MA, Baroni A. Alpha-MSH reduces the internalization of Staphylococcus aureus and down-regulates HSP 70, integrins and cytokine expression in human keratinocyte cell lines. Exp Dermatol. 2004;13:748–54.

    Article  CAS  PubMed  Google Scholar 

  13. Lipton JM, Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today. 1997;18:140–5.

    Article  CAS  PubMed  Google Scholar 

  14. Oktar BK, Alican I. Modulation of the peripheral and central inflammatory responses by alpha-melanocyte stimulating hormone. Curr Protein Pept Sci. 2002;3:623–8.

    Article  CAS  PubMed  Google Scholar 

  15. Wong KY, Rajora N, Boccoli G, Catania A, Lipton JM. A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation. 1997;4:37–41.

    CAS  PubMed  Google Scholar 

  16. Catania A, Cutuli M, Garofalo L, Airaghi L, Valenza F, Lipton JM, et al. Plasma concentrations and anti-l-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med. 2000;28:1403–7.

    Article  CAS  PubMed  Google Scholar 

  17. Catania A, Garofalo L, Cutuli M, Gringeri A, Santagostino E, Lipton JM. Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients. Peptides. 1998;19:1099–104.

    Article  CAS  PubMed  Google Scholar 

  18. Taherzadeh S, Sharma S, Chhajlani V, Gantz I, Rajora N, Demitri MT, et al. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte macrophages. Am J Physiol. 1999;276:R1289–94.

    CAS  PubMed  Google Scholar 

  19. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, et al. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol. 1996;156:2517–21.

    CAS  PubMed  Google Scholar 

  20. Ichiyama T, Zhao H, Catania A, Furukawa S, Lipton JM. Alpha-melanocyte-stimulating hormone inhibits NF-kappa B activation and I kappa B alpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol. 1999;157:359–65.

    Article  CAS  PubMed  Google Scholar 

  21. Manna SK, Aggarwal BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol. 1998;161:2873–80.

    CAS  PubMed  Google Scholar 

  22. Haycock JW, Rowe SJ, Cartledge S, Wyatt A, Ghanem G, Morandini R, et al. Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem. 2000;275:15629–36.

    Article  CAS  PubMed  Google Scholar 

  23. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides. 1996;17:675–9.

    Article  CAS  PubMed  Google Scholar 

  24. Star RA, Rajora N, Huang JJ, Stock RC, Catania A, Lipton JM. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA. 1995;92:8016–20.

    Article  CAS  PubMed  Google Scholar 

  25. Mountjoy KG, Wong J. Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol Cell Endocrinol. 1997;128:171–7.

    Article  CAS  PubMed  Google Scholar 

  26. Gantz I, Fong TM. The melanocortin system. Am J Physiol Endocrinol Metab. 2003;284:E468–74.

    CAS  PubMed  Google Scholar 

  27. Rees JL. Genetics of hair and skin color. Annu Rev Genet. 2003;37:67–90.

    Article  CAS  PubMed  Google Scholar 

  28. Seeley RJ, Drazen DL, Clegg DJ. The critical role of the melanocortin system in the control of energy balance. Annu Rev Nutr. 2004;24:133–49.

    Article  CAS  PubMed  Google Scholar 

  29. Hardy SJ, Christodoulides M, Weller RO, Heckels JE. Interactions of Neisseria meningitidis with cells of the human meninges. Mol Microbiol. 2000;36:817–29.

    Article  CAS  PubMed  Google Scholar 

  30. McGuinness BT, Clarke IN, Lambden PR, Barlow AK, Poolman JT, Jones DM, et al. Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet. 1991;337:514–7.

    Article  CAS  PubMed  Google Scholar 

  31. Christodoulides M, Makepeace BL, Partridge K, Kaur D, Fowler MI, Weller RO, et al. Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, pro-inflammatory and growth-factor cytokines. Infect Immun. 2002;70:4035–44.

    Article  CAS  PubMed  Google Scholar 

  32. Cheng Z, Xiong ZM, Subbarayan M, Chen XY, Gambhir SS. Cu-64-labeled alpha-melanocyte-stimulating hormone analog for MicroPET imaging of melanocortin 1 receptor expression. Bioconjug Chem. 2007;18:765–72.

    Article  CAS  PubMed  Google Scholar 

  33. Stephens DS, Edwards KM, Morris FMG. Pili and outer membrane appendages on Neisseria meningitidis in the cerebrospinal fluid of an infant. J Infect Dis. 1982;146:568.

    CAS  PubMed  Google Scholar 

  34. Brogden KA, Guthmiller JM, Salzet M, Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol. 2005;6:558–64.

    CAS  PubMed  Google Scholar 

  35. Kowalska K, Carr DB, Lipkowski AW. Direct antimicrobial properties of substance P. Life Sci. 2002;71:747–50.

    Article  CAS  PubMed  Google Scholar 

  36. Goumon Y, Lugardon K, Kieffer B, Lefevre JF, Van Dorsselaer A, Aunis D, et al. Characterization of antibacterial COOH-terminal proenkephalin-A-derived peptides (PEAP) in infectious fluids: importance of enkelytin, the antibacterial PEAP(209–237) secreted by stimulated chromaffin cells. J Biol Chem. 1998;273:29847–56.

    Article  CAS  PubMed  Google Scholar 

  37. Shimizu M, Shigeri Y, Tatsu Y, Yoshikawa S, Yumoto N. Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation. Antimicrob Agents Chemother. 1998;42:2745–6.

    CAS  PubMed  Google Scholar 

  38. Vouldoukis I, Shai Y, Nicolas P, Mor A. Broad spectrum antibiotic activity of skin-PYY. FEBS Lett. 1996;380:237–40.

    Article  CAS  PubMed  Google Scholar 

  39. Gonzalez-Rey E, Chorny A, Varela N, Robledo G, Delgado M. Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am J Pathol. 2006;168:1921–30.

    Article  CAS  PubMed  Google Scholar 

  40. Gonzalez-Rey E, Chorny A, Robledo G, Delgado M. Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med. 2006;203:563–71.

    Article  CAS  PubMed  Google Scholar 

  41. Bateman A, MacLeod RJ, Lembessis P, Hu J, Esch F, Solomon S. The isolation and characterization of a novel corticostatin/defensin-like peptide from the kidney. J Biol Chem. 1996;271:10654–9.

    Article  CAS  PubMed  Google Scholar 

  42. Kastenbauer S, Koedel U, Brzoska T, Luger TA, Pfister HW. Failure of alpha-melanocyte stimulating hormone to attenuate cerebral complications in experimental pneumococcal meningitis. J Neuroimmunol. 2001;116:56–61.

    Article  CAS  PubMed  Google Scholar 

  43. Cutuli M, Cristiani S, Lipton JM, Catania A. Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol. 2000;67:233–9.

    CAS  PubMed  Google Scholar 

  44. Gorter AD, Oostrik J, van der Ley P, Hiemstra PS, Dankert J, van Alphen L. Involvement of lipooligosaccharides of Haemophilus influenzae and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog. 2003;34:121–30.

    Article  CAS  PubMed  Google Scholar 

  45. Tatro JB. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation. 1996;3:259–84.

    Article  CAS  PubMed  Google Scholar 

  46. Robinson SJ, Healy E. Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene. 2002;21:8037–46.

    Article  CAS  PubMed  Google Scholar 

  47. Kiss M, Kemeny L, Gyulai R, Michel G, Husz S, Kovacs R, et al. Effects of the neuropeptides substance P, calcitonin gene-related peptide and alpha-melanocyte-stimulating hormone on the IL-8/IL-8 receptor system in a cultured human keratinocyte cell line and dermal fibroblasts. Inflammation. 1999;23:557–67.

    Article  CAS  PubMed  Google Scholar 

  48. Lindberg C, Hjorth E, Post C, Winblad B, Schultzberg M. Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone. Neurotox Res. 2005;8:267–76.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

P.K. was a PhD student supported by the British Skin Foundation. The work was supported by funding from the British Skin Foundation and the Meningitis Research Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Myron Christodoulides.

Additional information

Responsible Editor: G. Wallace.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, P., Williams, J.N., Durkin, K.L. et al. Neuropeptide α-MSH exerts pro-inflammatory effects on Neisseria meningitidis infection in vitro. Inflamm. Res. 59, 105–113 (2010). https://doi.org/10.1007/s00011-009-0076-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00011-009-0076-9

Keywords

Navigation